ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,883Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 917

$557K Total Retail Price of All Prescriptions

Rank: 87 out of 917

575 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 575 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 575 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,556 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 319 318 1 5
OMEPRAZOLE 299 279 2 4
LISINOPRIL 290 266 3 1
SIMVASTATIN 257 242 4 2
TAMSULOSIN HCL 253 249 5 25
METFORMIN HCL 214 202 6 8
LEVOTHYROXINE SODIUM 212 211 7 3
LOSARTAN POTASSIUM 206 206 8 13
ATORVASTATIN CALCIUM 184 183 9 14
ZOLPIDEM TARTRATE 180 168 10 21
PREDNISONE 176 173 11 34
WARFARIN SODIUM 174 173 12 10
ATENOLOL 162 162 13 12
PRAVASTATIN SODIUM 138 130 14 20
ALLOPURINOL 132 128 15 31
HYDROCODONE-ACETAMINOPHEN 132 128 S3 15 6
FLUTICASONE PROPIONATE 118 113 17 26
TRAZODONE HCL 108 106 18 22
FUROSEMIDE 106 104 19 7
POTASSIUM CHLORIDE 100 98 20 16
CRESTOR 100 93 20 30
LOVASTATIN 99 99 22 19
LOSARTAN-HYDROCHLOROTHIAZIDE 98 91 23 62
DONEPEZIL HCL 96 96 24 32
CITALOPRAM HBR 96 96 24 15
FENOFIBRATE 92 75 26 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 82 27 42
TRAMADOL HCL 83 83 28 28
NEXIUM 83 74 28 60
ZETIA 82 82 30 93
HYDROCHLOROTHIAZIDE 80 80 31 9
METHYLPREDNISOLONE 80 78 31 201
METOPROLOL SUCCINATE 77 77 33 18
AZITHROMYCIN 75 73 34 61
GABAPENTIN 73 72 35 17
TRIAMTERENE-HCTZ 68 68 36 36
CIPROFLOXACIN HCL 62 60 37 72
DOXAZOSIN MESYLATE 62 62 37 74
OXYBUTYNIN CHLORIDE 56 55 39 76
DICLOFENAC SODIUM 55 53 40 117
NAMENDA 54 54 41 43
GLIPIZIDE 52 52 42 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.